Skip to main content
SpringerLink
Log in

Therapie der Sklerodermie

Behandlungsoptionen nach den EUSTAR-Empfehlungen

  • Kollagenosen
  • Published:
rheuma plus Aims and scope

Das optimale therapeutische Management der Sklerodermie (SSc) stellt immer eine Herausforderung dar, ist doch die Ätiologie der Erkrankung unklar. Bei der systemischen Sklerodermie handelt es sich um eine klinisch heterogene Multiorganerkrankung.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Authors
  1. Vera Ferincz
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ferincz, V. Therapie der Sklerodermie. rheuma plus 11, 24–28 (2012). https://doi.org/10.1007/s12688-012-0058-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12688-012-0058-9

Search

Navigation